Proposed Intranasal Route for Drug Administration in the Management of Central Nervous System Manifestations of COVID-19

Authors: Siddiqui, Ruqaiyyah;

Khan, Naveed Ahmed

Source: ACS Chemical Neuroscience

Full text

: https://doi.org/10.1021/acschemneuro.0c00288

Abstract

There is mounting evidence of the central nervous system manifestations associated with COVID-19, particularly in severe cases. Up to 25% of COVID-19 cases exhibit neurological manifestations associated with COVID-19. In view of the devastating nature of the disease due to severe acute respiratory syndrome coronavirus 2, here we debate intranasal drug delivery, in addition to intravenous delivery, as a therapeutic strategy in the management of COVID-19 cases with central nervous system involvement.

Rights

https://acsopenscience.org/researchers/open-access/

Cite as

Siddiqui, R. & Khan, N. 2020, 'Proposed Intranasal Route for Drug Administration in the Management of Central Nervous System Manifestations of COVID-19', ACS Chemical Neuroscience, 11(11), pp. 1523-1524. https://doi.org/10.1021/acschemneuro.0c00288

Downloadable citations

HTML BIB RIS

Identifiers

DOI: https://doi.org/10.1021/acschemneuro.0c00288

Repository URI: https://researchportal.hw.ac.uk/en/publications/20520210-e7e0-49a5-8201-63d43b63709e